LONDON–(BUSINESS WIRE)–BenevolentAI (Euronext Amsterdam: BAI), a leading clinical-stage AI drug discovery company, announces that it will participate at the upcoming Jefferies London Healthcare Conference from 15-17 November. Nick Keher, Chief Financial Officer of BenevolentAI is scheduled to present at 10.20 AM GMT on Thursday, 17 November 2022. The presentation will be live-streamed on the following … [Read more…]
BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that it received prequalification from the World Health Organization (WHO) for its live attenuated varicella vaccine on November 3, 2022. This marks the first WHO prequalified Chinese varicella vaccine and the fourth SINOVAC vaccine to … [Read more…]
GOLETA, Calif.–(BUSINESS WIRE)–Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will present at the following investor conferences: Stifel 2022 Healthcare Conference on Tuesday, November 15 at 10:20 a.m. Eastern Time Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30 at … [Read more…]
–Company also strengthens Board of Directors with appointments of Luca Santarelli and Michael Tomsicek– BASEL, Switzerland & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cimeio Therapeutics, a biotechnology company developing a novel approach to cell therapies, today announced the acceptance of two abstracts for the company’s pipeline programs to be presented at the American Society of Hematology meeting in December … [Read more…]
MURFREESBORO, Tenn.–(BUSINESS WIRE)–National HealthCare Corporation (NYSE American: NHC), the nation’s oldest publicly traded senior health care company, announced today net operating revenues and government stimulus income for the quarter ended September 30, 2022 totaled $270,843,000 compared to $276,737,000 for the quarter ended September 30, 2021, a decrease of 2.1%. The net operating revenues decrease during … [Read more…]
WASHINGTON–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) is proud to commemorate the thirtieth anniversary of the highly effective 340B drug pricing program. On November 4, 1992, US President George H.W. Bush signed the bipartisan Veterans Health Care Act, containing the 340B program, into law. Since then, 340B has assisted thousands of nonprofit safety net providers – including … [Read more…]
PARSIPPANY, N.J.–(BUSINESS WIRE)–IVERIC bio, Inc. (Nasdaq: ISEE) today announced that it has submitted to the U.S. Food and Drug Administration (FDA) the first part of its New Drug Application (NDA) for rolling review of avacincaptad pegol (ACP, also known as Zimura®) a novel investigational complement C5 inhibitor, for the treatment of geographic atrophy (GA) secondary … [Read more…]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [(“Merrimack” or the “Company”)] today announced its third quarter 2022 financial results for the period ended September 30, 2022. “During the third quarter we continued to see the benefits of reduced operating expenses,” said Gary Crocker, Chairman of Merrimack’s Board of Directors. “We will continue to monitor developments … [Read more…]
Tender offer part of refinancing that is expected to include an increased revolving credit facility. Refinancing will improve debt maturity profile and result in decreased interest expense. PHILADELPHIA–(BUSINESS WIRE)–Rite Aid Corporation (NYSE: RAD) (“we,” “us,” “our” or the “Company”) today announced that it has commenced a tender offer (the “Tender Offer”) to purchase for cash … [Read more…]
BostonGene to Showcase Cancer Diagnostic and Treatment Recommendation Test WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene today announced that an abstract has been accepted for online publication for the Association for Molecular Pathology (AMP) 2022 Annual Meeting & Expo, which will be held November 3 – 5, 2022, at the Phoenix Convention Center in Phoenix, AZ. BostonGene will also … [Read more…]
